معالجة فرط نشاط الغدة الدرقية من نوع غريفزGraves باليود المشع -131 (نتائج المعالجة على مرضى من الساحل السوري)

Authors

  • بسام سعد
  • حمزة شبيب

Abstract

قمنا بمراجعة الملفات الطبية لمرضى مصابين بفرط نشاط الغدة الدرقية من نوع غريفز عولجوا باليود -131 في الفترة بين 1996و 2002 . من بين 135 مريضاً أمكن الحصول على معلومات كافية عن نتائج المتابعة لمدة 12 شهراً على الأقل عند 65 منهم . أعطي اليود -131 بجرعة واحدة بمعدل ( 200 مايكروكوري / غ من وزن الغدة مصححة على نسبة قبط يود 100% بعد 24 ساعة ) . أوقفت المعالجة الدوائية بال Methimazole قبل أسبوع من إعطاء جرعة اليود-131 . اعتبرت المعالجة ناجحة عند الحصول على سواء أو قصور درقيين .

في فحوص المتابعة التي أجريت بعد ثلاثة أشهر من تطبيق المعالجة وجدت نسبة 80% نجاح للمعالجة أما في الفحوص التي أجريت بعد 12 شهراً فقد وصلت النسبة إلى 89% .

إن النتائج المشاهدة قريبة من النسب المشاهدة في المصادر العلمية المختلفة .

 

We reviewed and analysed medical records of patients with Graves, hyperthyroidism treated with Iodine-131 from 1996 to 2002 . Of 135 patients , 65 had adequate follow-up for at least 12 months after therapy . Iodine-131 was delivered as a single dose ( 200 micro Ci /g thyroid tissue corrected to 100 % 24-h I-131 uptake ) . Methimazole treatment was discontinued 1 week befor , and continued for 1 month after I-131 therapy .

The therapy was considered successful when euthyroidism or hypothyroidism were achieved . In the follow-up after 3 and 12 months post-therapy the cure rates were 80% and 89% respectively . The found results were consistent with those mentioned in the litrature .

Downloads

Published

2019-01-14

How to Cite

1.
سعد ب, شبيب ح. معالجة فرط نشاط الغدة الدرقية من نوع غريفزGraves باليود المشع -131 (نتائج المعالجة على مرضى من الساحل السوري). Tuj-hlth [Internet]. 2019Jan.14 [cited 2024May1];27(1). Available from: https://journal.tishreen.edu.sy/index.php/hlthscnc/article/view/6328

Issue

Vol. 27 No. 1 (2005): العلوم الصحية

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

 Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series   .  The Readers have the right to send, print and subscribe to the initial version of the article, and the title of  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series  Publisher

journal uses a CC BY-NC-SA license which mean

You are free to:

  • Adapt — remix, transform, and build upon the material
  •  
  • The licensor cannot revoke these freedoms as long as you follow the license terms.

 

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.
  • ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Most read articles by the same author(s)